New Suture Anchor for Hip Surgery Cleared

The Bio Mini-Revo, a suture anchor system, has been cleared for marketing by the U.S. Food and Drug Administration. The system is indicated for use during treatment of patients undergoing surgical repair of the labrum within the hip joint.

The approved system is a 3.1 diameter screw-in anchor. The device is manufactured from the company’s patented, self reinforced 96L/4D Poly Lactic Acid, Linvatec. The advantage of this material is that it provides a balance of strength with enhanced absorption of the material over time. This design prevents the requirement that patients undergo a second surgery to remove the anchor.

Another feature of the device is pre-threading. The device includes #2 Hi-Fi high strength suture. Currently, this is the only system available on the market that includes these biomaterial characteristics and mechanical strength.

Surgeons note that the device can improve access to the hip during repair procedures. In addition, it minimizes the risks associated with failures of anchor fixation.

This is the newest product added to the company’s line of products manufactured with Linvatec, which particularly include other tools for hip arthroscopy.

August 15, 2008 Related topics: Product Approval & Certification, Orthopedic

Today on
Hospital Buyer

HospitalBuyer Undergoing Surgery

HospitalBuyer is on long-term hiatus. We may come back in new and improved form in the future, but...

CT Scans Alter ER Decision-Making About Appendicitis

Data collected from CT scanning of the abdomen and pelvis can alter decision-making by clinicians regarding those patients...

MediNotes Purchase Completed by Eclipsys

Eclipsys Corporation announced that the acquisition (pdf) of MediNotes was finalized. MediNotes is now a wholly owned subsidiary...

http://www.hospitalbuyer.com